Open-label Study to Assess the Safety and Efficacy of CDP6038 (Olokizumab) in Patients Who Completed RA0056
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
55 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- 401
Brussels, Belgium
- 400
Liège, Belgium
- 206
Essex, United Kingdom
- 208
Southampton, United Kingdom
- 209
Torquay, United Kingdom
- 166
Mesa, Arizona, United States
- 154
Phoenix, Arizona, United States
- 118
Scottsdale, Arizona, United States
- 103
Hot Springs, Arkansas, United States
- 127
Covina, California, United States
- 148
La Jolla, California, United States
- 184
Long Beach, California, United States
- 177
Los Angeles, California, United States
- 104
Palo Alto, California, United States
- 129
Santa Maria, California, United States
- 164
Upland, California, United States
- 141
Hamden, Connecticut, United States
- 111
Lewes, Delaware, United States
- 151
DeBary, Florida, United States
- 114
Jupiter, Florida, United States
- 157
Tampa, Florida, United States
- 183
Tampa, Florida, United States
- 116
Idaho Falls, Idaho, United States
- 160
Moline, Illinois, United States
- 168
Springfield, Illinois, United States
- 133
Cedar Rapids, Iowa, United States
- 172
Kansas City, Kansas, United States
- 185
Saint Clair Shores, Michigan, United States
- 112
St Louis, Missouri, United States
- 134
St Louis, Missouri, United States
- 102
Lincoln, Nebraska, United States
- 171
Freehold, New Jersey, United States
- 152
Toms River, New Jersey, United States
- 174
Brooklyn, New York, United States
- 170
Charlotte, North Carolina, United States
- 150
Cincinnati, Ohio, United States
- 100
Dayton, Ohio, United States
- 110
Oklahoma City, Oklahoma, United States
- 165
Duncansville, Pennsylvania, United States
- 105
Nashville, Tennessee, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 7 Mar 2011
- Primary completion
- 1 May 2013
- Completion
- 5 Aug 2013
- Last update posted
- 14 Apr 2022
- Registered enrollment
- 190
- Registry id
- NCT01296711
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.